Cigna Group's Express Scripts said on Monday it would add three Humira biosimilars drugs from German drugmaker Boehringer and Swiss company Novartis to its list of preferred drugs.
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest
The watchlist from June posted a gain of 8.91% last month, outperforming the SPDR S&P 500 Trust ETF by 2.43% and Vanguard's Dividend Appreciation ETF by 2.41%. The top 15 dividend growth stocks for Ju
Heading into 2023, the S&P 500 stocks averaged 6,5% dividend growth over the previous five years. In Q1 2023, the average dividend growth of the index was 10.07%, the fourth consecutive quarter in dou

Cigna: Buy While It's Still Cheap And Not Loved

05:28pm, Thursday, 29'th Jun 2023
The Cigna Group investors who picked the May lows have benefited from its recovery. The selloff triggered by concerns over Medicare procedures costs also hit it less hard. Despite the recent recovery,
Zacks.com users have recently been watching Cigna (CI) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
Demand for Intuitive Surgical's and Cigna's products and services should grow. The two companies are each leaders of their respective industries.
Investors need to pay close attention to Cigna (CI) stock based on the movements in the options market lately.
Cigna's (CI) strong Evernorth and Cigna Healthcare segments, growing medical membership and a positive 2023 outlook poise it well for growth.
Insurance stocks are plunging nearly across the board today. This appears to be true whether we're talking about sector leaders like Humana (NYSE: HUM ), UnitedHealth (NYSE: UNH ), Elevance Health (NY
Cigna (CI) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Cigna is a global health insurer with strong revenue growth potential from its pharmacy benefits manager and insurance segments. The company has a solid capital allocation strategy, including business
This article is part of our monthly series where we highlight five companies that are large-cap, relatively safe, dividend-paying and are offering large discounts to their historical norms. We go over

Here's Why Cigna (CI) is a Strong Value Stock

10:42am, Friday, 09'th Jun 2023
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE